Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshimichi Sakai is active.

Publication


Featured researches published by Yoshimichi Sakai.


Mutation Research Letters | 1990

Inhibitory action of peony root extract on the mutagenicity of benzo[a]pyrene

Yoshimichi Sakai; Hisamitsu Nagase; Youki Ose; Hideaki Kito; Takahiko Sato; Makoto Kawai; Mizuo Mizuno

The inhibitory effects of peony root extract on the mutagenicity of benzo[a]pyrene (B [a]p) have been investigated in the Salmonella typhimurium reversion test. Four kinds of experiments were performed: direct chemical reaction (1) between peony root extract and B [a]p, and (2) between peony root extract and active metabolite(s) of B [a]p, (3) inhibition of metabolic processes of B[a]p with S9 mix, and (4) inhibition of activation on mutagenicity. Peony root extract interfered with the action of enzymes in the S9 mix, and inactivated the activity of B[a]p metabolites. The bio-antimutagenic effect was assayed by reversion in Salmonella typhimurium TA98 and TA100.


Mutation Research\/genetic Toxicology | 1988

Effects of medicinal plant extracts from Chinese herbal medicines on the mutagenic activity of benzo[a]pyrene.

Yoshimichi Sakai; Hisamitsu Nagase; Youki Ose; Takahiko Sato; Makoto Kawai; Mizuo Mizuno

The effects of medicinal plants on the mutagenicity of benzo[a]pyrene were studied with Salmonella typhimurium tester strains. The chosen medicinal plants are very frequently used as Chinese herbal medicines. Each medicinal plant was extracted with hot water, which is similar to the method used in Chinese medicinal treatment. Cinnamomi cortex, Rhei rhizoma, Scutellariae radix and Rehmanniae radix were found to decrease the mutagenic activity of benzo[a]pyrene. Atractylodis rhizoma also reduced the mutagenicity of benzo[a]pyrene, but this was not certain, because it showed a killing effect on the cell survival test. Bupleuri radix and Aurantii nobilis pericarpium had an enhancing effect, but then neither of these extracts is itself mutagenic. Each medicinal plant extract showed a different effect on the mutagenicity of benzo[a]pyrene. These effects were classified into 5 types: (I) decreasing effect, (II) killing effect, (III) enhancing effect, (IV) enhancing and decreasing effect and (V) inactive.


Mutation Research Letters | 1986

Antimutagenicity of extracts from crude drugs in Chinese medicines.

Yoshimichi Sakai; Hisamitsu Nagase; Youki Ose; Takahiko Sato; Atsuko Yamada; Makoto Hibi; Fujizo Yamada

The antimutagenicity of extracts from crude drugs was studied by the Ames bioassay system. The crude drugs chosen were medical plants used very frequently as Chinese medicines. Each crude drug was extracted with hot water similar to the method of Chinese medical treatment. Antimutagenicity of the extract was found with 4 kinds of crude drugs, Paeoniae radix, Bupleuri radix, Hoelen and Glycyrrhizae radix. Each extract of the crude drug showed a different type of antimutagenic action from the others.


Journal of Chromatography B: Biomedical Sciences and Applications | 1996

Determination of the 8-methyl ether of xanthurenic acid in human serum by high-performance liquid chromatography with fluorescence detection

Junzo Imai; Isao Yoshida; Kyoko Murayama; Yoshimichi Sakai; Hidenori Shimizu; Tooru Sumi; Tsuneo Iguchi; Makoto Kawai; Seiji Yamaguchi

We developed a simple and sensitive assay for the 8-methyl ether of xanthurenic acid in serum by high-performance liquid chromatography with fluorescence detection (excitation at 340 nm, emission at 450 nm). The compound under study in serum samples was extracted with Sep-Pak C18 cartridge and the extract was applied to an octadecylsilane-bonded column (Nucleosil 5C18, 150 x 4 mm I.D.). The mobile phase used was a mixture of 0.05 M sodium acetate buffer (pH 6.0), containing 5 mM sodium 1-octanesulfonate and 0.1 mM Na2EDTA, and acetonitrile (93:7, v/v). The 8-methyl ether of xanthurenic acid from serum samples was sufficiently separated to be clearly distinguishable. The quantification limit was 2 x 10(-14) mol, which was sensitive enough to detect 8-methyl ether of xanthurenic acid in serum from normal subjects. The method was applied to samples from patients with deficiency in tryptophan metabolism, xanthurenic acid/3-hydroxy kynurenineuria and showed a striking elevation in serum 8-methyl ether of xanthurenic acid.


Planta Medica | 2001

Inhibitory Effect of Magnolol and Honokiol from Magnolia obovata on Human Fibrosarcoma HT-1080 Invasiveness in vitro

Hisamitsu Nagase; Koji Ikeda; Yoshimichi Sakai


Phytotherapy Research | 2003

Inhibitory effect of magnolol on tumour metastasis in mice.

Koji Ikeda; Yoshimichi Sakai; Hisamitsu Nagase


Chemical & Pharmaceutical Bulletin | 1989

Differential Inhibitory Effects of Various Herb Extracts on the Activities of Reverse Transcriptase and Various Deoxyribonucleic Acid (DNA) Polymerases

Katsuhiko Ono; Hideo Nakane; Zeng-Mu Meng; Youki Ose; Yoshimichi Sakai; Mizuo Mizuno


Mutation Research | 1992

Modulating effect of tanshinones on mutagenic activity of Trp-P-1 and benzo[a]pyrene in Salmonella typhimurium

Motoyasu Sato; Takahiko Sato; Youki Ose; Hisamitsu Nagase; Hideaki Kito; Yoshimichi Sakai


Mutation Research-genetic Toxicology and Environmental Mutagenesis | 2006

In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens.

Junichiro Saito; Yoshimichi Sakai; Hisamitsu Nagase


Eisei kagaku | 1994

Rapid Screening Method for Pesticides as the Cause Substances of Toxicosis by TLC.

Hiromi Mori; Takahiko Sato; Hisamitsu Nagase; Yoshimichi Sakai; Sachiko Yamaguchi; Yukiko Iwata; Rieko Hashimoto; Futoshi Yamazaki; Michiharu Hayata

Collaboration


Dive into the Yoshimichi Sakai's collaboration.

Top Co-Authors

Avatar

Hisamitsu Nagase

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Takahiko Sato

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Youki Ose

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Mizuo Mizuno

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Hideaki Kito

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Futoshi Yamazaki

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Koji Ikeda

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Motoyasu Sato

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Atsuko Yamada

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Isao Yoshida

Gifu Pharmaceutical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge